New respiratory syncytial virus (RSV) prevention products significantly reduce infant hospitalization rates, highlighting the ...

Maternal respiratory syncytial virus (RSV) vaccination and nirsevimab were associated with a reduction in RSV-associated ...

A single dose of the adult RSV vaccine RSVPreF3 OA prevented RSV–lower respiratory tract disease during 3 virus seasons in adults aged 60+.

The Centers for Disease Control and Prevention (CDC) and seven US pediatric medical centers report a notable association ...

Interim surveillance network data showed lower hospitalization rates following the availability of prevention products.

New multi-center US study finds RSV co-infection in children under two is not linked to worse clinical outcomes, challenging ...

Recent data shows that most infants are receiving RSV vaccination in the US, but rates vary by race and birth month.

The rate dropped to about 5.5 infant deaths per 1,000 live births in 2024, according to CDC provisional data. That’s down ...

There was a significant drop in the number of babies hospitalized with RSV this year; a positive news story that can be ...

The Centers for Disease Control and Prevention May 8 released an analysis that found declines in hospitalizations for infants infected with respiratory syncytial virus during the 2024-2025 RSV season.

(Reuters) -Infant hospitalizations due to respiratory syncytial virus (RSV) infections in the United States dropped as much ...

A mum has spoken of the terrifying moment her five-week-old daughter stopped breathing - and thanked the emergency crew who ...